Literature DB >> 21454745

Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease.

Aarti A Kenjale1, Katherine L Ham, Thomas Stabler, Jennifer L Robbins, Johanna L Johnson, Mitch Vanbruggen, Grayson Privette, Eunji Yim, William E Kraus, Jason D Allen.   

Abstract

Peripheral arterial disease (PAD) results in a failure to adequately supply blood and oxygen (O(2)) to working tissues and presents as claudication pain during walking. Nitric oxide (NO) bioavailability is essential for vascular health and function. Plasma nitrite (NO(2)(-)) is a marker of vascular NO production but may also be a protected circulating "source" that can be converted to NO during hypoxic conditions, possibly aiding perfusion. We hypothesized that dietary supplementation of inorganic nitrate in the form of beetroot (BR) juice would increase plasma NO(2)(-) concentration, increase exercise tolerance, and decrease gastrocnemius fractional O(2) extraction, compared with placebo (PL). This was a randomized, open-label, crossover study. At each visit, subjects (n = 8) underwent resting blood draws, followed by consumption of 500 ml BR or PL and subsequent blood draws prior to, during, and following a maximal cardiopulmonary exercise (CPX) test. Gastrocnemius oxygenation during the CPX was measured by near-infrared spectroscopy. There were no changes from rest for [NO(2)(-)] (152 ± 72 nM) following PL. BR increased plasma [NO(2)(-)] after 3 h (943 ± 826 nM; P ≤ 0.01). Subjects walked 18% longer before the onset of claudication pain (183 ± 84 s vs. 215 ± 99 s; P ≤ 0.01) and had a 17% longer peak walking time (467 ± 223 s vs. 533 ± 233 s; P ≤ 0.05) following BR vs. PL. Gastrocnemius tissue fractional O(2) extraction was lower during exercise following BR (7.3 ± 6.2 vs. 10.4 ± 6.1 arbitrary units; P ≤ 0.01). Diastolic blood pressure was lower in the BR group at rest and during CPX testing (P ≤ 0.05). These findings support the hypothesis that NO(2)(-)-related NO signaling increases peripheral tissue oxygenation in areas of hypoxia and increases exercise tolerance in PAD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454745      PMCID: PMC3119136          DOI: 10.1152/japplphysiol.00071.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  55 in total

1.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

2.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.

Authors:  T Lauer; M Preik; T Rassaf; B E Strauer; A Deussen; M Feelisch; M Kelm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  Stability and reproducibility of brachial artery flow-mediated dilation.

Authors:  Michael A Welsch; Jason D Allen; James P Geaghan
Journal:  Med Sci Sports Exerc       Date:  2002-06       Impact factor: 5.411

Review 4.  Critical issues in peripheral arterial disease detection and management: a call to action.

Authors:  Jill J F Belch; Eric J Topol; Giancarlo Agnelli; Michel Bertrand; Robert M Califf; Denis L Clement; Mark A Creager; J Donald Easton; James R Gavin; Philip Greenland; Graeme Hankey; Peter Hanrath; Alan T Hirsch; Jürgen Meyer; Sidney C Smith; Frank Sullivan; Michael A Weber
Journal:  Arch Intern Med       Date:  2003-04-28

5.  The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash.

Authors:  Mirco Govoni; Emmelie A Jansson; Eddie Weitzberg; Jon O Lundberg
Journal:  Nitric Oxide       Date:  2008-08-30       Impact factor: 4.427

6.  Cardiorespiratory impact of the nitric oxide synthase inhibitor L-NAME in the exercising horse.

Authors:  C A Kindig; L L Gallatin; H H Erickson; M R Fedde; D C Poole
Journal:  Respir Physiol       Date:  2000-04

Review 7.  Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector?

Authors:  Chris E Cooper
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

8.  Mitochondria recycle nitrite back to the bioregulator nitric monoxide.

Authors:  H Nohl; K Staniek; B Sobhian; S Bahrami; H Redl; A V Kozlov
Journal:  Acta Biochim Pol       Date:  2000       Impact factor: 2.149

9.  Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery.

Authors:  R O Cannon; A N Schechter; J A Panza; F P Ognibene; M E Pease-Fye; M A Waclawiw; J H Shelhamer; M T Gladwin
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  106 in total

1.  Beetroot juice reduces infarct size and improves cardiac function following ischemia-reperfusion injury: Possible involvement of endogenous H2S.

Authors:  Fadi N Salloum; Gregory R Sturz; Chang Yin; Shabina Rehman; Nicholas N Hoke; Rakesh C Kukreja; Lei Xi
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-30

2.  Dietary nitrate - a slow train coming.

Authors:  Eddie Weitzberg; Jon O Lundberg
Journal:  J Physiol       Date:  2011-11-15       Impact factor: 5.182

Review 3.  Nitric oxide formation versus scavenging: the red blood cell balancing act.

Authors:  Benjamin Y Owusu; Ryan Stapley; Rakesh P Patel
Journal:  J Physiol       Date:  2012-06-11       Impact factor: 5.182

4.  Dose dependent effects of nitrate supplementation on cardiovascular control and microvascular oxygenation dynamics in healthy rats.

Authors:  Scott K Ferguson; Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole
Journal:  Nitric Oxide       Date:  2014-04-21       Impact factor: 4.427

5.  "Beet" the cold: beetroot juice supplementation improves peripheral blood flow, endothelial function, and anti-inflammatory status in individuals with Raynaud's phenomenon.

Authors:  Anthony I Shepherd; Joseph T Costello; Stephen J Bailey; Nicolette Bishop; Alex J Wadley; Steven Young-Min; Mark Gilchrist; Harry Mayes; Danny White; Paul Gorczynski; Zoe L Saynor; Heather Massey; Clare M Eglin
Journal:  J Appl Physiol (1985)       Date:  2019-07-25

6.  Effect of acute dietary nitrate supplementation on sympathetic vasoconstriction at rest and during exercise.

Authors:  Christopher J de Vries; Darren S DeLorey
Journal:  J Appl Physiol (1985)       Date:  2019-05-16

Review 7.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 8.  Functional Nitric Oxide Nutrition to Combat Cardiovascular Disease.

Authors:  Nathan S Bryan
Journal:  Curr Atheroscler Rep       Date:  2018-03-17       Impact factor: 5.113

9.  Effects of nitrate supplementation via beetroot juice on contracting rat skeletal muscle microvascular oxygen pressure dynamics.

Authors:  Scott K Ferguson; Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Jason D Allen; Andrew M Jones; Timothy I Musch; David C Poole
Journal:  Respir Physiol Neurobiol       Date:  2013-04-11       Impact factor: 1.931

10.  "Beet It".

Authors:  Jay H Traverse
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.